Seek Returns

Insmed (INSM) Stock Analysis

This is a peer-relative look at Insmed (INSM): its performance, risk, profitability, growth, financial strength, dividend, and valuation are each measured against its Pharmaceuticals, Biotechnology & Life Sciences peers, so every number reads in context rather than in isolation.

Company Profile

Company profile fields for Insmed (INSM)
Profile ItemINSM
NameInsmed Incorporated
Country/RegionUnited States
GICS SectorHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
GICS Sub-IndustryBiotechnology
Market Capitalization25.10 billion USD
CurrencyUSD
ExchangeNasdaq
Listing DateJune 1, 2000
Security TypeCommon Stock

Price Performance

Cumulative Growth

INSM
GSPC
Loading price history…
Insmed (INSM) vs. S&P 500 (GSPC): Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Insmed (INSM) and S&P 500 (GSPC). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Insmed (INSM) and S&P 500 (GSPC). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Insmed (INSM) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: INSMIndustry group median
Total Return (1Y)-39.17%24.62%
Total Return (3Y, Annualized)70.17%20.37%
Total Return (5Y, Annualized)28.96%-4.02%

Risk Profile

Drawdown History

INSM
GSPC
Loading price history…
Insmed (INSM) vs. S&P 500 (GSPC): Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Insmed (INSM) and S&P 500 (GSPC). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Insmed (INSM) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: INSMIndustry group median
Volatility (1Y, Annualized)63.09%66.36%
Beta (5Y)0.800.93
Max Drawdown (5Y)-56.54%-80.19%

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
Each dot is a stock plotted by 1-year volatility (risk) and 1-year return. INSM is highlighted; the dashed line is the Capital Allocation Line from the risk-free rate through the industry median — dots above it are stronger on a risk-adjusted basis.

Risk-Adjusted Metrics

Insmed (INSM) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: INSMIndustry group median
Sharpe Ratio (1Y)-0.690.36
Sortino Ratio (1Y)-1.040.58

Profitability

ROE (TTM)

Insmed (INSM) has negative ROE of -72.45%. That can come from trailing losses or negative book equity, so it is a warning state rather than a clean capital-efficiency measure.

INSM

Pharmaceuticals, Biotechnology & Life Sciences industry group

-72.45%

Group distribution
Max
109.18%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
INSM
-72.45%
Min
-167.77%
Largest peers
LLY
86.02%
NVS
24.33%
AZN
22.57%
JNJ
20.02%
MRK
5.06%
INSM
-72.45%
ABBV
--
Loading chart…
Where Insmed (INSM) stands on ROE within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Net Margin (TTM)

Insmed (INSM) has negative net margin of -39.85%. The trailing period ended in a net loss, so the bottom-line conversion read is a warning rather than a profitability strength.

INSM

Pharmaceuticals, Biotechnology & Life Sciences industry group

-39.85%

Group distribution
Max
18.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%
INSM
-39.85%
Largest peers
LLY
31.90%
AZN
17.68%
NVS
17.49%
JNJ
16.20%
ABBV
15.67%
MRK
3.64%
INSM
-39.85%
Loading chart…
Where Insmed (INSM) stands on net margin within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Operating Margin (TTM)

Insmed (INSM) has negative operating margin of -15.60%. Core operations were loss-making before interest and taxes over the trailing period.

INSM

Pharmaceuticals, Biotechnology & Life Sciences industry group

-15.60%

Group distribution
Max
83.12%
Q3
14.77%
Median
0.00%
INSM
-15.60%
Q1
-78.82%
Min
-207.40%
Largest peers
LLY
53.66%
ABBV
39.59%
MRK
35.22%
NVS
34.27%
AZN
29.57%
JNJ
25.74%
INSM
-15.60%
Loading chart…
Where Insmed (INSM) stands on operating margin within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Profitability Metrics

Insmed (INSM) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: INSMIndustry group median
ROE (TTM)-72.45%-26.66%
ROA (TTM)-17.25%-12.50%
Net Margin (TTM)-39.85%0.00%
Operating Margin (TTM)-15.60%0.00%
Gross Margin (TTM)84.40%37.87%

Growth

Revenue Growth

Insmed (INSM) grew revenue 66.73%, in the upper peer quartile. The top line is expanding faster than at most industry peers, which points to share gains or stronger pricing.

Loading chart…
Insmed (INSM): Revenue Growth across different time periods, set against Pharmaceuticals, Biotechnology & Life Sciences industry-group medians.

EPS Growth

No usable EPS growth is available for Insmed (INSM) this period, so the earnings-momentum read is skipped.

Loading chart…
Insmed (INSM) doesn't report EPS Growth this period; the bars show the Pharmaceuticals, Biotechnology & Life Sciences industry-group medians on their own.

Growth Metrics

Insmed (INSM) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: INSMIndustry group median
Revenue Growth (YoY)66.73%11.45%
Revenue Growth (3Y CAGR)35.20%9.94%
EPS Growth (YoY)--4.28%
EPS Growth (3Y CAGR)--4.17%

Financial Strength

Current Ratio (MRQ)

Insmed (INSM) has current ratio of 2.86, in the healthier middle range for its industry. The short-term asset cushion looks balanced relative to peers rather than stretched thin.

INSM

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.86

Group distribution
Max
25.13
Q3
12.13
Median
5.52
INSM
2.86
Q1
2.47
Min
0.10
Largest peers
INSM
2.86
LLY
1.39
MRK
1.35
JNJ
1.02
AZN
1.01
NVS
0.88
ABBV
0.87
Loading chart…
Where Insmed (INSM) stands on current ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Debt / Equity (MRQ)

Insmed (INSM) has debt-to-equity ratio of 1.01, in the higher-leverage quartile for its industry. The heavier reliance on borrowing can make earnings, rates, or refinancing conditions matter more.

INSM

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.01

Group distribution
Max
1.42
INSM
1.01
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00
Largest peers
NVS
1.29
LLY
1.23
MRK
1.20
INSM
1.01
AZN
0.66
JNJ
0.55
ABBV
--
Loading chart…
Where Insmed (INSM) stands on debt-to-equity ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Financial Strength Metrics

Insmed (INSM) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: INSMIndustry group median
Current Ratio (MRQ)2.865.52
Debt / Equity (MRQ)1.010.15
Net Debt / EBITDA--1.08

Dividends

Dividend Yield (TTM)

Insmed (INSM) pays no dividend, leaving dividend yield at 0.00% this period. Shareholders may still receive value through reinvestment or buybacks, but there is no dividend income to compare here.

INSM

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

Group distribution
INSM
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Largest peers
NVS
2.88%
ABBV
2.40%
MRK
2.29%
JNJ
1.94%
AZN
1.73%
LLY
0.49%
INSM
0.00%
Loading chart…
Where Insmed (INSM) stands on dividend yield within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Dividend Payout Ratio (TTM)

Insmed (INSM) paid no earnings out as dividends this period, leaving payout ratio at 0.00%. There is no dividend payout to size against earnings.

INSM

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

Group distribution
INSM
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Largest peers
MRK
343.43%
ABBV
117.35%
NVS
90.46%
JNJ
80.12%
AZN
45.38%
LLY
21.71%
INSM
0.00%
Loading chart…
Where Insmed (INSM) stands on payout ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Dividend Metrics

Insmed (INSM) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: INSMIndustry group median
Dividend Yield (TTM)0.00%0.00%
Dividend Payout Ratio (TTM)0.00%0.00%

Valuation

P/E Ratio (TTM)

No usable P/E ratio is available for Insmed (INSM) this period, so the trailing-earnings valuation read is skipped.

INSM

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Group distribution
Max
85.34
Q3
43.46
Median
26.69
Q1
13.30
Min
0.07
INSM
--
Largest peers
MRK
148.21
ABBV
50.05
LLY
43.95
JNJ
41.92
NVS
31.02
AZN
26.37
INSM
--
Loading chart…
Insmed (INSM) doesn’t report P/E ratio this period; the box shows the Pharmaceuticals, Biotechnology & Life Sciences group’s distribution and the dots its largest members.

P/S Ratio (TTM)

Insmed (INSM) trades at 16.52 on P/S ratio, roughly in the peer group’s normal range. The market is not making a strong cheap-or-rich statement about its revenue base.

INSM

Pharmaceuticals, Biotechnology & Life Sciences industry group

16.52

Group distribution
Max
58.18
Q3
25.77
INSM
16.52
Median
7.30
Q1
3.01
Min
0.01
Largest peers
INSM
16.52
LLY
13.95
ABBV
7.80
JNJ
6.69
MRK
5.37
NVS
5.35
AZN
4.63
Loading chart…
Where Insmed (INSM) stands on P/S ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

P/B Ratio (MRQ)

Insmed (INSM) trades at 34.55 on P/B ratio, above the industry benchmark range. Investors are putting an unusually rich price on each dollar of book equity relative to peers.

INSM

Pharmaceuticals, Biotechnology & Life Sciences industry group

34.55

Group distribution
INSM
34.55
Max
13.53
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59
Largest peers
INSM
34.55
LLY
29.96
NVS
8.25
JNJ
8.16
MRK
8.06
AZN
5.59
ABBV
-112.34
Loading chart…
Where Insmed (INSM) stands on P/B ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Valuation Metrics

Insmed (INSM) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: INSMIndustry group median
P/E Ratio (TTM)--26.69
P/S Ratio (TTM)16.527.30
P/B Ratio (MRQ)34.553.25
Free Cash Flow Yield (TTM)-1.82%-1.66%